Medived Innovations Private Limited - Due diligence report

A 360° intelligence report on Medived: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

2007-02-27 Bangalore, Karnataka Active Unlisted Active Non-Compliant
Share
MI Medived Innovations Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Medived — 360° Intelligence Report

Generated from MCA filings & public records
56/100
Trust Score
Moderate

Medived is assessed as Moderate with a Trust Score of 56/100. Medived is an active private limited indian non-government company incorporated in 2007, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Medived Innovations Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
48/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.

Charges position: 2 open (3.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Department Of Biotechnology2 48.0 cr
Compliance Score: 48/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2018 - filings overdue.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
UDAY PURI 01234567 Director 01/04/2018 6 yrs Approved
DINESH PURI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • DINESH PURI has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 65
Growth signals & trust indicators
Operating for 19+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (48/100).
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment40/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 3.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view44/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 13 events
31 Jul 2019
Director ceased
HARINARAYAN SHARMA
30 Sep 2018
Last AGM held
Annual general meeting
31 Mar 2018
Latest balance sheet
Filed with ROC
02 Jun 2014
Securities allotted
12222 Equity Shares Without Differential Rights - 6.69 cr raised
13 May 2013
Director appointed
UDAY PURI (Director)
26 Sep 2011
Securities allotted
131800 Equity Shares Without Differential Rights - 1.32 cr raised
Securities allotted
60700 Equity Shares Without Differential Rights - 60.70 Lakh raised
20 May 2011
Director ceased
SATYAM CHOUDARY CHERUKURI
16 May 2011
Charge created
Department Of Biotechnology - 1.50 cr
25 Oct 2010
Director ceased
RANJAN RAMDAS PAI
15 Jun 2007
Director ceased
SUBBARAO PARVATHANENI
27 Feb 2007
Incorporated
Registered with Roc Bangalore
Director appointed
DINESH PURI (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a majority stake as per the FY 2018 annual return.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rohit Exim Private Limited U51498DL1996PTC077586 Delhi, Delhi, India
Eshcol Laboratories Private Limited U73100TN2008PTC067774 Chennai, Tamil Nadu, India
Meld Healthcare Products Private Limited U33100GJ2005PTC046485 Ahmedabad, Gujarat, India
Magnys Life Sciences Private Limited U24304MH2017PTC298669 Thane, Maharashtra, India
Nectar Lifestyles Private Limited U24100DL2006PTC148846 New Delhi, Delhi, India
Bravohealthcare U24239MH2000PLC127301 Navi Mumbai, Maharashtra, India
Healing Heritage Producer Company Limited U00003OR2005PTC008500 Cuttack, Orissa, India
Emsons Organics Limited U51102PB2002PLC025452 Tehsil Rajpura, Punjab, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Medived before audits and certifications: compliance score 48/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Medived: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Medived - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Medived pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Medived - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Medived an active company?

Medived has MCA status “Active” with a compliance score of 48/100 (Caution Indicated).

Is Medived financially healthy?

Medived has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Medived?

Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Medived?

Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Medived have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Medived up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 48/100 (Caution Indicated).

Is it risky to lend to Medived?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.